Prestige Consumer Healthcare Inc.
For the period ended Mar 31, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed May 14, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. FORM 10-K SUMMARY
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Prestige Consumer Healthcare Inc. | |
| By: | /s/ Christine Sacco |
| Name: | Christine Sacco |
| Title: | Chief Financial Officer & Chief Operating Officer |
| Date: | May 14, 2026 |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ RONALD M. LOMBARDI | Director, Presidentand Chief Executive Officer | May 14, 2026 |
| Ronald M. Lombardi | (Principal Executive Officer) | |
| /s/ CHRISTINE SACCO | Chief Financial Officer & Chief Operating Officer | May 14, 2026 |
| Christine Sacco | (Principal Financial Officer and | |
| Principal Accounting Officer) | ||
| /s/ JOHN E. BYOM | Director | May 14, 2026 |
| John E. Byom | ||
| /s/ CELESTE A. CLARK | Director | May 14, 2026 |
| Celeste A. Clark | ||
| /s/ JAMES C. D' ARECCA | Director | May 14, 2026 |
| James C. D’Arecca | ||
| /s/ SHEILA A. HOPKINS | Director | May 14, 2026 |
| Sheila A. Hopkins | ||
| /s/ JOHN F. KELLY | Director | May 14, 2026 |
| John F. Kelly | ||
| /s/ DAWN M. ZIER | Director | May 14, 2026 |
| Dawn M. Zier | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.